Tag: generic market entry
Dec, 6 2025
Recent Patent Cases and Generic Delays: 2023-2025 Examples
Despite FDA approval, generic drugs in the U.S. face average delays of 3.2 years before reaching patients due to patent litigation. From 2023 to 2025, brand-name companies used patent thickets to extend monopolies, costing Medicare billions and leaving patients without affordable options.